“…In Treg, which have high levels of GITR expression, GITR signaling participates in regulation of proliferation and modulation of suppressive function ( 5 , 20 , 21 ). Targeting GITR via anti-GITR agonistic antibody ( 22 , 23 , 24 , 25 ), recombinant Fc-GITRL proteins ( 26 , 27 , 28 ), or engineered Chimeric Antigen Receptor T cells (CAR-T) expressing recombinant receptors with the GITR cytosolic domain ( 29 , 30 , 31 ) can exert potent therapeutic activities. However, GITR-mediated intracellular signaling remains only partially characterized.…”